Loading clinical trials...
Loading clinical trials...
Prevalence of Primary Aldosteronism in Patients With Atrial Fibrillation (ERETRIA Trial)
This is an observational prospective cross-sectional study, investigating the prevalence of primary aldosteronism in patients with atrial fibrillation.
Age
18 - 100 years
Sex
ALL
Healthy Volunteers
No
Ippokratio General Hospital
Thessaloniki, Greece
Start Date
September 1, 2021
Primary Completion Date
September 1, 2024
Completion Date
September 1, 2024
Last Updated
August 3, 2023
120
ESTIMATED participants
Screening and Confirmatory diagnostic test for primary aldosteronism
DIAGNOSTIC_TEST
Lead Sponsor
Aristotle University Of Thessaloniki
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05963698